Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Characterize Epidemiology, Clinical and Genetic Features of Kallmann Syndrome in Finland
This study is enrolling participants by invitation only.
Study NCT00623116 Information provided by Hospital for Children and Adolescents, Finland
First Received: January 11, 2008 Last Updated: February 13, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Kallmann Syndrome
Additional conditions recognized in this trial
Septo-Optic Dysplasia
Syndrome
More general conditions related to this trial
Congenital Abnormalities
Disease
Endocrine System Diseases
Genetic Diseases, Inborn
Gonadal Disorders
Hypogonadism
Nervous System Diseases
Nervous System Malformations
Pathologic Processes
Sex Differentiation Disorders
Urogenital Abnormalities
Additional drug interventions recognized in this trial
Estrogens
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
More general drug interventions related to this trial
Anabolic Agents
Androgens
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Hospital for Children and Adolescents, Finland
Back to top of Main Content
